News Briefing channel feed – Endpoints News

News Briefing channel feed

Recursion’s $200M offering; Sanofi invests $40M in Vigil Neuroscience

10 months ago

Taysha’s $75M offering; Augustine raises €17M

10 months ago

Zealand Pharma aims to raise $900M; Boehringer discontinues three Phase 2 trials

10 months ago

Corrected: Entrada raises $100M for Duchenne development; eFFECTOR winds down

10 months ago

Layoffs at Ginkgo and Xellia; Melodia and Alivexis ink $275M partnership

10 months ago

Forbion's new €75M fund; Cara Therapeutics to cut workforce after trial failure

10 months ago

A new obesity biotech; UroGen aims to raise $107M

10 months ago

Argenx drops post-Covid syndrome program; Mirum picks a dose for bile duct disease drug

10 months ago

Takeda signs option deal for TKI inhibitor; Enveda's $55M raise

10 months ago

Avidity’s $300M offering; Rapport raises $174M

10 months ago

Alzheon raises $100M; Regeneron ends mid-stage trial

11 months ago

ADC startup raises €30M; Cyrus Biotechnology to spin out Levitate Bio

11 months ago

Shionogi inks deal for preclinical hearing loss therapies; Alvotech’s refinancing pact

11 months ago

Replimune aims for accelerated approval of melanoma therapy; Structure's upsized $476M offering

11 months ago

ArriVent inks ADC deal with Alphamab; Annexon's $125M offering

11 months ago

Corrected: Vilya raises $21M in Series A extension; Shionogi to open research center in San Diego

11 months ago

Novartis shares updated data for BTK inhibitor; Astellas resubmits BLA for cancer drug after CRL

11 months ago

Compugen, Nxera disclose milestone payments; Insmed aims for $650M offering

11 months ago

Insmed, Merus announce public offerings; AI startup raises $13M seed round

11 months ago

Agios sells rights to glioma drug to Royalty Pharma; Cargo’s $110M placement

11 months ago

Bicycle’s $555M placement; Tango Therapeutics scraps cancer program

11 months ago

Dyne's $305M offering; Nanobiotix delays Ph2 readout

11 months ago

Lyra to lay off 75% of its workers; Dupixent nears COPD decision

11 months ago

Foghorn’s $110M offering; Novovax investor withdraws proxy campaign

11 months ago

First page Previous page 6 7 8910 11 12 Next page Last page